Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101459634 | 10145963 | 4 | F | 20130926 | 20151216 | 20140501 | 20151231 | EXP | PT-INFARMED-L201404-100 | PT-MERCK-1404PRT013055 | MERCK | 19.58 | YR | M | Y | 74.00000 | KG | 20151231 | CN | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101459634 | 10145963 | 1 | PS | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 5 MG, QD | U | 20830 | 5 | MG | CHEWABLE TABLET | QD | |||||
| 101459634 | 10145963 | 2 | SS | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | CHEWABLE TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101459634 | 10145963 | 1 | Asthma |
| 101459634 | 10145963 | 2 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101459634 | 10145963 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101459634 | 10145963 | Petechiae | |
| 101459634 | 10145963 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101459634 | 10145963 | 1 | 2006 | 201312 | 0 | |
| 101459634 | 10145963 | 2 | 201312 | 20140421 | 0 |